{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:34:33Z","timestamp":1761899673711,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.preghy.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T03:05:41Z","timestamp":1647572741000},"page":"109-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Women\u2019s perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia"],"prefix":"10.1016","volume":"28","author":[{"given":"Sarah","family":"Heimberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana Lopes","family":"Perdigao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Kuriloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Amegashie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarosh","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2022.03.005_b0005","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019;133(1):1.","DOI":"10.1097\/AOG.0000000000003020"},{"issue":"4","key":"10.1016\/j.preghy.2022.03.005_b0010","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/10641955.2015.1090581","article-title":"Racial Disparities in Comorbidities, Complications, and Maternal and Fetal Outcomes in Women With Preeclampsia\/eclampsia","volume":"34","author":"Shahul","year":"2015","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.preghy.2022.03.005_b0015","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","author":"Rana","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.preghy.2022.03.005_b0020","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.preghy.2022.03.005_b0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000477903","article-title":"Spanish Group for the Study of Angiogenic Markers in P. Update on the Diagnosis and Prognosis of Preeclampsia with the Aid of the sFlt-1\/ PlGF Ratio in Singleton Pregnancies","volume":"43","author":"Herraiz","year":"2018","journal-title":"Fetal Diagn. Ther."},{"issue":"1","key":"10.1016\/j.preghy.2022.03.005_b0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.preghy.2022.03.005_b0035","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","article-title":"Randomized Interventional Study on Prediction of Preeclampsia\/Eclampsia in Women with Suspected Preeclampsia: INSPIRE","volume":"74","author":"Cerdeira","year":"2019","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.preghy.2022.03.005_b0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1515\/cclm-2017-0443","article-title":"Use of the sFlt-1\/PlGF ratio to rule out preeclampsia requiring delivery in women with suspected disease. Is the evidence reproducible?","volume":"56","author":"Sabria","year":"2018","journal-title":"Clin. Chem. Lab Med."},{"issue":"4","key":"10.1016\/j.preghy.2022.03.005_b0045","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.116.08620","article-title":"Prediction of Preeclampsia Using the Soluble fms-Like Tyrosine Kinase 1 to Placental Growth Factor Ratio: A Prospective Cohort Study of Unselected Nulliparous Women","volume":"69","author":"Sovio","year":"2017","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.preghy.2022.03.005_b0050","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/HYPERTENSIONAHA.118.12205","article-title":"Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients","volume":"73","author":"Lopes Perdigao","year":"2019","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.preghy.2022.03.005_b0055","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/10641955.2016.1148162","article-title":"KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes","volume":"35","author":"Salahuddin","year":"2016","journal-title":"Hypertens Pregnancy"},{"issue":"7","key":"10.1016\/j.preghy.2022.03.005_b0060","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.preghy.2022.03.005_b0065","doi-asserted-by":"crossref","first-page":"e0126815","DOI":"10.1371\/journal.pone.0126815","article-title":"Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia","volume":"10","author":"March","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.preghy.2022.03.005_b0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10641955.2013.784788","article-title":"Clinical characterization and outcomes of preeclampsia with normal angiogenic profile","volume":"32","author":"Rana","year":"2013","journal-title":"Hypertens Pregnancy"},{"issue":"9","key":"10.1016\/j.preghy.2022.03.005_b0075","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1055\/s-0035-1557924","article-title":"Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015\/018, December 2013)","volume":"75","author":"Stepan","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.preghy.2022.03.005_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/4096847","article-title":"sFlt-1\/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective","volume":"2019","author":"Hodel","year":"2019","journal-title":"Dis. Markers"},{"issue":"4","key":"10.1016\/j.preghy.2022.03.005_b0085","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3111\/13696998.2010.535285","article-title":"Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective","volume":"13","author":"Hadker","year":"2010","journal-title":"J. Med. Econ."},{"issue":"6","key":"10.1016\/j.preghy.2022.03.005_b0090","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/uog.15997","article-title":"sFlt-1\/PlGF ratio test for pre-eclampsia: an economic assessment for the UK","volume":"48","author":"Vatish","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2022.03.005_b0095","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12913-018-3406-1","article-title":"Economic assessment of the use of the sFlt-1\/PlGF ratio test to predict preeclampsia in Germany","volume":"18","author":"Schlembach","year":"2018","journal-title":"BMC Health Serv. Res."},{"issue":"18","key":"10.1016\/j.preghy.2022.03.005_b0100","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1080\/14767058.2016.1242122","article-title":"Budget impact analysis of sFlt-1\/PlGF ratio as prediction test in Italian women with suspected preeclampsia","volume":"30","author":"Frusca","year":"2017","journal-title":"J. Matern. Fetal Neonatal. Med."},{"issue":"2","key":"10.1016\/j.preghy.2022.03.005_b0105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of Preeclampsia-Related Adverse Outcomes With the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)\/PlGF (Placental Growth Factor)-Ratio in the Clinical Routine: A Real-World Study","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.preghy.2022.03.005_b0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s12884-019-2518-x","article-title":"Psychological and social consequences of non-invasive prenatal testing (NIPT): a scoping review","volume":"19","author":"Labonte","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"10.1016\/j.preghy.2022.03.005_b0115","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1515\/jpm-2019-0450","article-title":"Women's decisional conflict in the pathway of prenatal screening and testing: an explorative study within Finnish public maternity care","volume":"48","author":"Chen","year":"2020","journal-title":"J. Perinat. Med."},{"issue":"6","key":"10.1016\/j.preghy.2022.03.005_b0120","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s10897-017-0118-3","article-title":"Women's Experience with Non-Invasive Prenatal Testing and Emotional Well-being and Satisfaction after Test-Results","volume":"26","author":"van Schendel","year":"2017","journal-title":"J. Genet. Couns."},{"issue":"1","key":"10.1016\/j.preghy.2022.03.005_b0125","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-016-1195-2","article-title":"Perspectives, preferences and needs regarding early prediction of preeclampsia in Dutch pregnant women: a qualitative study","volume":"17","author":"Crombag","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"10.1016\/j.preghy.2022.03.005_b0130","first-page":"321","article-title":"Preeclampsia screening from the patient's perspective","volume":"9","author":"Luchian","year":"2016","journal-title":"J. Med. Life"},{"issue":"12","key":"10.1016\/j.preghy.2022.03.005_b0135","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.midw.2014.04.006","article-title":"The psychological impact of providing women with risk information for pre-eclampsia: a qualitative study","volume":"30","author":"Harris","year":"2014","journal-title":"Midwifery"},{"issue":"6","key":"10.1016\/j.preghy.2022.03.005_b0140","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/HYPERTENSIONAHA.117.09499","article-title":"Estimating the Cost of Preeclampsia in the Healthcare System: Cross-Sectional Study Using Data From SCOPE Study (Screening for Pregnancy End Points)","volume":"70","author":"Fox","year":"2017","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.preghy.2022.03.005_b0145","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/1471-0528.12259","article-title":"Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia","volume":"120","author":"Schnettler","year":"2013","journal-title":"BJOG"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778922000356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778922000356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:57:32Z","timestamp":1761897452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778922000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"alternative-id":["S2210778922000356"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2022.03.005","relation":{},"ISSN":["2210-7789"],"issn-type":[{"type":"print","value":"2210-7789"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Women\u2019s perspectives and attitudes towards the utility of angiogenic biomarkers in preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}